ECO Animal Health Group (EAH) Competitors

ECO Animal Health Group logo
GBX 59.45 -2.55 (-4.11%)
As of 11:12 AM Eastern

EAH vs. BXP, ANCR, DNL, VLG, STX, PXS, CHLL, CEL, MXC, and RGT

Should you be buying ECO Animal Health Group stock or one of its competitors? The main competitors of ECO Animal Health Group include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Diurnal Group (DNL), Venture Life Group (VLG), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Celadon Pharmaceuticals (CEL), Argent BioPharma (MXC), and Argent BioPharma (RGT). These companies are all part of the "drug manufacturers - specialty & generic" industry.

ECO Animal Health Group vs.

ECO Animal Health Group (LON:EAH) and Beximco Pharmaceuticals (LON:BXP) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, valuation and community ranking.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Beximco Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Beximco Pharmaceuticals has higher revenue and earnings than ECO Animal Health Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£89.42M0.45£1.05M£0.022,972.50
Beximco Pharmaceuticals£43.08B0.00£5.33B£0.08495.88

Beximco Pharmaceuticals has a net margin of 12.37% compared to ECO Animal Health Group's net margin of 1.17%. Beximco Pharmaceuticals' return on equity of 10.99% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group1.17% 2.13% 2.14%
Beximco Pharmaceuticals 12.37%10.99%6.97%

ECO Animal Health Group has a beta of -0.05, indicating that its stock price is 105% less volatile than the S&P 500. Comparatively, Beximco Pharmaceuticals has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.

ECO Animal Health Group received 188 more outperform votes than Beximco Pharmaceuticals when rated by MarketBeat users. Likewise, 75.90% of users gave ECO Animal Health Group an outperform vote while only 64.67% of users gave Beximco Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
ECO Animal Health GroupOutperform Votes
296
75.90%
Underperform Votes
94
24.10%
Beximco PharmaceuticalsOutperform Votes
108
64.67%
Underperform Votes
59
35.33%

ECO Animal Health Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.7%. Beximco Pharmaceuticals pays an annual dividend of GBX 3 per share and has a dividend yield of 7.6%. ECO Animal Health Group pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Beximco Pharmaceuticals pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio.

77.9% of ECO Animal Health Group shares are held by institutional investors. Comparatively, 1.7% of Beximco Pharmaceuticals shares are held by institutional investors. 21.7% of ECO Animal Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than ECO Animal Health Group. MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for ECO Animal Health Group. ECO Animal Health Group's average media sentiment score of 0.00 equaled Beximco Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
ECO Animal Health Group Neutral
Beximco Pharmaceuticals Neutral

Summary

Beximco Pharmaceuticals beats ECO Animal Health Group on 10 of the 18 factors compared between the two stocks.

Get ECO Animal Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for EAH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EAH vs. The Competition

MetricECO Animal Health GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£40.27M£1.21B£5.68B£2.12B
Dividend Yield0.94%3.04%5.32%5.16%
P/E Ratio2,972.50134.0389.851,942.96
Price / Sales0.452,544.841,031.77372,563.84
Price / Cash6.0510.2546.0929.32
Price / Book0.483.255.063.06
Net Income£1.05M£155.98M£113.46M£185.64M
7 Day Performance-6.08%0.23%-1.31%0.47%
1 Month Performance-8.96%-0.50%3.87%3.84%
1 Year Performance-45.21%108.42%21.17%146.97%

ECO Animal Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EAH
ECO Animal Health Group
N/AGBX 59.45
-4.1%
N/A-42.9%£40.27M£89.42M2,972.50234Gap Down
BXP
Beximco Pharmaceuticals
N/AGBX 38
flat
N/A-1.5%£169.52M£43.08B475.005,500
ANCR
Animalcare Group
N/AGBX 242
+1.7%
N/A+26.0%£146.10M£76.10M3,025.00220
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
VLG
Venture Life Group
N/AGBX 34
-1.4%
N/A-9.1%£43.20M£51.41M3,400.00165Gap Down
STX
Shield Therapeutics
N/AGBX 2.68
-4.3%
N/A-36.2%£20.96M£21.47M-67.0040,000
PXS
Provexis
N/AGBX 0.56
-7.5%
N/A-2.9%£12.61M£426,168.0043.754Gap Down
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007
CEL
Celadon Pharmaceuticals
N/AGBX 15
-11.8%
N/A-85.1%£10.33M£11,258.00-187.502,780News Coverage
Gap Down
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£3.10MN/A-24.12N/AGap Down
High Trading Volume

Related Companies and Tools


This page (LON:EAH) was last updated on 2/12/2025 by MarketBeat.com Staff
From Our Partners